MK
Therapeutic Areas
MDxHealth Pipeline
| Drug | Indication | Phase |
|---|---|---|
| ConfirmMDx | Prostate Cancer (Risk assessment after negative biopsy) | Commercial |
| Genomic Prostate Score (GPS) | Prostate Cancer (Risk stratification for localized disease) | Commercial |
| SelectMDx | Prostate Cancer (Initial risk assessment for biopsy decision) | Commercial |
| ExoDx Prostate (EPI) | Prostate Cancer (Non-invasive, pre-biopsy risk assessment) | Commercial |
| ResolveMDx | Urinary Tract Infection (UTI) (Pathogen ID & Antibiotic Susceptibility) | Commercial |